Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satisfaction study of split-dose Bocouture with double frequency
2017-004278-32Phase 4Active
- Sponsor
- Falck
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in rhytides (2 arms), sponsored by Falck. Primary endpoint: Primary: Satisfaction Scale score over time compared with baseline. Started Dec 2020; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on 2017-004278-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004278-32.